@ARTICLE{
author={Link Mark S,...,Mitrovic Veselin,...,Apostolovic Svetlana R,Djordjevic-Radojkovic Danijela,Celic Vera P,Majstorovic Anka R,Cemerlic-Adjic Nada B,Bjelobrk Marija S,Despotovic Nebojsa,Erceg Predrag,Ilic Stevan N,Ilic Bojan I,Krotin Mirjana K,Djokovic Aleksandra,Miloradovic Vladimir M,Djokic I,Otasevic Petar M,Tasic Nebojsa M,Potpara Tatjana S,Polovina Marija M,Putnikovic Biljana,Kalezic T,Seferovic Petar M,Milinkovic Ivan M,Tavciovski Dragan,Davicevic Zaklina S,Vasiljevic-Pokrajcic Zorana M,Mitrovic Predrag M,Vujisic-Tesic Bosiljka D,Ostojic Miodrag C,...,Tesic Milorad B,...,(broj koautora 2696)},
year={2017},
title={Stroke and Mortality Risk in Patients With Various Patterns of Atrial Fibrillation Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48)},
journal={CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY},
volume={10},
number={1},
pages={-},
document_type={Article},
}